Vir Biotechnology Inc (VIR)
Gross profit margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit (ttm) | US$ in thousands | 63,487 | 64,403 | 57,937 | 46,430 | 39,435 | 43,718 | 397,033 | 339,169 | 1,434,154 | 2,171,240 | 1,916,938 | 2,160,388 | 886,333 | 133,454 | -31,919 | -218,145 | -141,207 | -194,586 | -163,716 | -180,051 |
| Revenue (ttm) | US$ in thousands | 73,109 | 78,618 | 72,140 | 56,343 | 46,679 | 51,681 | 427,211 | 397,246 | 1,580,474 | 2,368,441 | 2,099,722 | 2,316,395 | 1,087,060 | 277,605 | 175,080 | 67,363 | 67,245 | 67,315 | 67,364 | 1,181 |
| Gross profit margin | 86.84% | 81.92% | 80.31% | 82.41% | 84.48% | 84.59% | 92.94% | 85.38% | 90.74% | 91.67% | 91.29% | 93.27% | 81.53% | 48.07% | -18.23% | -323.84% | -209.99% | -289.07% | -243.03% | -15,245.64% |
December 31, 2024 calculation
Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $63,487K ÷ $73,109K
= 86.84%
The gross profit margin of Vir Biotechnology Inc has exhibited significant fluctuations over the analyzed period. Starting with negative margins in the first half of 2020, indicating that the company's cost of goods sold exceeded its revenue from sales. However, there was a notable turnaround by the end of 2021, with the gross profit margin reaching positive territory and showing consistent improvement through 2024.
The company experienced a remarkable recovery in profitability as indicated by its gross profit margin rising to levels above 80% from the 2022 fiscal year onwards. This positive trend suggests that Vir Biotechnology Inc has been able to effectively control its production costs and increase the efficiency of its operations, resulting in a healthier bottom line.
Overall, the trajectory of Vir Biotechnology Inc's gross profit margin reflects a significant turnaround from negative margins to strong positive margins, indicating improved operational performance and potentially greater financial stability for the company in the long run.
Peer comparison
Dec 31, 2024